(Q43035123)

12 November 2017

title

Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors (English)

1 reference

12 November 2017

1 reference

1 reference

1

1 reference

12 November 2017

author name string

George V Papatheodoridis

2

1 reference

12 November 2017

Emanuel K Manesis

3

1 reference

12 November 2017

Nikolaos Chrysanthos

4

1 reference

12 November 2017

Georgia Kafiri

5

1 reference

12 November 2017

Kalliopi Petraki

6

1 reference

12 November 2017

Emilia Hadziyannis

7

1 reference

12 November 2017

Helen Pandelidaki

8

1 reference

12 November 2017

Rodessa Zafiropoulou

9

1 reference

12 November 2017

Savvas Savvas

10

1 reference

12 November 2017

John Koskinas

11

1 reference

12 November 2017

Athanasios J Archimandritis

12

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

The American Journal of Gastroenterology

12 November 2017

published in

1 reference

12 November 2017

volume

102

1 reference

12 November 2017

issue

3

1 reference

12 November 2017

page(s)

634-641

1 reference

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Worsening of steatosis and fibrosis progression in hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Steatosis affects chronic hepatitis C progression in a genotype specific way

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Hepatitis C and steatosis: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Review article: hepatic steatosis and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Steatosis: co-factor in other liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Natural history of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.01025.X

10.1111/J.1572-0241.2006.01025.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference